Why GW Pharmaceuticals Stock Lost 17.7% in February – Madison.com

Why GW Pharmaceuticals Stock Lost 17.7% in February
Madison.com
The company is valued at roughly 166 times forward sales — a daunting multiple that underscores the risk of betting big on the future of marijuana-related industries. 10 stocks we like better than GW Pharmaceuticals. When investing geniuses David and …

and more Continue Reading

Comments are closed.